These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 10828486
1. Platelet-derived microparticles stimulate coronary artery smooth muscle cell mitogenesis by a PDGF-independent mechanism. Weber A, Köppen HO, Schrör K. Thromb Res; 2000 Jun 01; 98(5):461-6. PubMed ID: 10828486 [Abstract] [Full Text] [Related]
2. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis. Osinski MT, Schrör K. Biochem Pharmacol; 2000 Aug 01; 60(3):381-7. PubMed ID: 10856433 [Abstract] [Full Text] [Related]
3. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW. Circ Res; 2005 Feb 04; 96(2):172-9. PubMed ID: 15625285 [Abstract] [Full Text] [Related]
4. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases. Cospedal R, Abedi H, Zachary I. Cardiovasc Res; 1999 Mar 04; 41(3):708-21. PubMed ID: 10435043 [Abstract] [Full Text] [Related]
5. Platelet-derived growth factor BB-induced p38 mitogen-activated protein kinase activation causes cell growth, but not apoptosis, in vascular smooth muscle cells. Yamaguchi H, Igarashi M, Hirata A, Susa S, Ohnuma H, Tominaga M, Daimon M, Kato T. Endocr J; 2001 Aug 04; 48(4):433-42. PubMed ID: 11603565 [Abstract] [Full Text] [Related]
6. Red wine polyphenols inhibit vascular smooth muscle cell migration through two distinct signaling pathways. Iijima K, Yoshizumi M, Hashimoto M, Akishita M, Kozaki K, Ako J, Watanabe T, Ohike Y, Son B, Yu J, Nakahara K, Ouchi Y. Circulation; 2002 May 21; 105(20):2404-10. PubMed ID: 12021228 [Abstract] [Full Text] [Related]
7. Platelet surface membranes are highly mitogenic for coronary artery smooth muscle cells--A novel mechanism for sustained proliferation after vessel injury? Weber AA, Zucker TP, Schrör K. Biochem Biophys Res Commun; 1999 Jun 07; 259(2):341-3. PubMed ID: 10362510 [Abstract] [Full Text] [Related]
8. Antiproliferative effect of L-NAME on rat vascular smooth muscle cells. El Mabrouk M, Singh A, Touyz RM, Schiffrin EL. Life Sci; 2000 Aug 18; 67(13):1613-23. PubMed ID: 10983855 [Abstract] [Full Text] [Related]
9. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression. Zhan Y, Kim S, Izumi Y, Izumiya Y, Nakao T, Miyazaki H, Iwao H. Arterioscler Thromb Vasc Biol; 2003 May 01; 23(5):795-801. PubMed ID: 12637337 [Abstract] [Full Text] [Related]
10. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smooth muscle cells. Kim TJ, Yun YP. Vascul Pharmacol; 2007 Jan 01; 46(1):43-51. PubMed ID: 16875883 [Abstract] [Full Text] [Related]
11. Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen. Grosser T, Zucker TP, Weber AA, Schulte K, Sachinidis A, Vetter H, Schrör K. Eur J Pharmacol; 1997 Jan 29; 319(2-3):327-32. PubMed ID: 9042608 [Abstract] [Full Text] [Related]
12. Functional properties of hyalocytes under PDGF-rich conditions. Noda Y, Hata Y, Hisatomi T, Nakamura Y, Hirayama K, Miura M, Nakao S, Fujisawa K, Sakamoto T, Ishibashi T. Invest Ophthalmol Vis Sci; 2004 Jul 29; 45(7):2107-14. PubMed ID: 15223783 [Abstract] [Full Text] [Related]
14. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Böhmer FD. Circ Res; 1999 Jul 09; 85(1):12-22. PubMed ID: 10400906 [Abstract] [Full Text] [Related]
15. The synergistic effect of PDGF-AA and IGF-1 on VSMC proliferation might be explained by the differential activation of their intracellular signaling pathways. Thömmes KB, Hoppe J, Vetter H, Sachinidis A. Exp Cell Res; 1996 Jul 10; 226(1):59-66. PubMed ID: 8660939 [Abstract] [Full Text] [Related]
16. Inhibitory mechanism of tranilast in human coronary artery smooth muscle cells proliferation, due to blockade of PDGF-BB-receptors. Watanabe S, Matsuda A, Suzuki Y, Kondo K, Ikeda Y, Hashimoto H, Umemura K. Br J Pharmacol; 2000 May 10; 130(2):307-14. PubMed ID: 10807667 [Abstract] [Full Text] [Related]
17. CD40 ligand (CD40L) does not stimulate proliferation of vascular smooth muscle cells. Hermann A, Schrör K, Weber AA. Eur J Cell Biol; 2002 Apr 10; 81(4):213-21. PubMed ID: 12018389 [Abstract] [Full Text] [Related]
18. Felodipine inhibits nuclear translocation of p42/44 mitogen-activated protein kinase and human smooth muscle cell growth. Yang Z, Madinova A, Kozai T, Joch H, Aebi U, Lüscher TF. Cardiovasc Res; 2002 Jan 10; 53(1):227-31. PubMed ID: 11744032 [Abstract] [Full Text] [Related]
19. Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A. Bönisch D, Weber AA, Wittpoth M, Osinski M, Schrör K. Mol Pharmacol; 1998 Aug 10; 54(2):241-8. PubMed ID: 9687564 [Abstract] [Full Text] [Related]